Product Description
Overall, the global thoracolumbar fixation market was valued at over $6.3 billion in 2024. This is expected to increase over the forecast period at a CAGR of 6.9% to reach over $10 billion.
The full report suite on the global market for thoracolumbar fixation includes segments for degenerative thoracolumbar fixation, deformity correction thoracolumbar fixation and trauma/tumor thoracolumbar fixation.
This report includes data for 65+ countries across 7 different regions. These regions are North America, Latin America, Western Europe, Central & Eastern Europe, Middle East, Asia-Pacific, and Africa.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Size & Growth Trends
- Procedure Numbers
- Market Drivers & Limiters
- Market Forecasts Until 2031, and Historical Data to 2024
- Recent Mergers & Acquisitions
- Company Profiles and Product Portfolios
- Leading Competitors
GLOBAL THORACOLUMBAR FIXATION MARKET TRENDS
The largest limiting factor for the spinal fusion market, including thoracolumbar fixation, is the development of motion preservation technology. LADs have not been as successful at cannibalizing thoracolumbar fixation devices as previously anticipated due to a lack of reimbursement and unfavorable clinical results, but with improvements in LADs, the thoracolumbar fixation market can be impacted.
GLOBAL THORACLUMBAR FIXATION MARKET SHARE INSIGHTS
- Medtronic was the leading competitor in the global thoracolumbar fixation market in 2024. Medtronic was more successful in North America compared to other regions. The company had a very strong presence in degenerative thoracolumbar fixation due to its CD Horizon® Legacy™ system, which was the world’s first polyetheretherketone (PEEK)-based pedicle screw/rod system. Medtronic has seen success with other products under the CD Horizon® brand, especially the CD Horizon® Solera Voyager. Medtronic also offers the TSRH® spinal system, which may be used in conjunction with its CROSSLINK® plates as a universal rod and hook system with applications in the degenerative, deformity and tumor/trauma segments of the spinal market. Medtronic also carried the Colorado 2™ product, which is used for treating scoliosis, and its TSRH-3D® system, which is used for treating lordosis or “sway back” deformity.
- DePuy Synthes was the second-leading competitor in the global thoracolumbar fixation market in 2024. DePuy’s shares was close to that of Medtronic. The company led the market in most countries in the Asia-Pacific and Latin American regions. DePuy Synthes’ anterior plates, the ANTEGRA™ and ANTEGRA-T™ plate systems, can be used in degenerative cases and trauma/tumor cases. DePuy Synthes offers a comprehensive line of deformity-based fusion products. This line includes EXPEDIUM® and MATRIX systems, both of which can be used for treating a broad scope of degenerative and deformity cases.
- Stryker was the third-leading competitor in the global thoracolumbar fixation market in 2024. The company held a strong position across North America and Western Europe, with an expanding presence in Asia-Pacific and Latin America. Stryker’s thoracolumbar fixation portfolio included systems such as the XIA® 4.5 Spinal System, XIA® 3 MIS System and AcuLIF™ Expandable Lumbar Interbody System, supporting procedures across degenerative, deformity and trauma/tumor indications. In 2025, Stryker sold its non-core spinal implant assets to Viscogliosi Brothers (VB) as part of a strategic realignment to focus on enabling technologies. This transaction included a number of its thoracolumbar fixation systems, which were transferred to VB’s portfolio. Despite the divestiture, Stryker’s influence on the market – particularly through its innovation in surgical navigation, robotics and integrated procedural solutions – continues to shape surgical practice and market trends globally.
MARKET SEMGENTATION SUMMARY
- Degenerative Market
- Deformity Market
- Trauma/Tumor Market
GLOBAL RESEARCH SCOPE SUMMARY
| Report Attribute | Details |
|---|---|
| Regions | North America (Canada, United States) Latin America (Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Dominican Republic, Ecuador, Guatemala, Mexico, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela) Western Europe (Austria, Benelux, France, Germany, Italy, Portugal, Scandinavia, Spain, Switzerland, United Kingdom) Central & Eastern Europe (Azerbaijan, Baltic States, Belarus, Bulgaria, Croatia, Czech Republic, Georgia, Greece, Hungary, Kazakhstan, Poland, Romania, Russia, Serbia, Slovakia, Slovenia, Turkey, Ukraine) Middle East (Bahrain, Iran, Israel, Kuwait, Oman, Qatar, Saudi Arabia, United Arab Emirates) Asia Pacific (Australia, Cambodia, China, Hong Kong, India, Indonesia, Japan, Kyrgyzstan, Macao, Malaysia, Mongolia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Uzbekistan, Vietnam) Africa (Algeria, Egypt, Ethiopia, Ghana, Kenya, Libya, Morocco, Nigeria, South Africa, Sudan, Uganda) |
| Base Year | 2024 |
| Forecast | 2025-2031 |
| Historical Data | 2021-2023 |
| Quantitative Coverage | Procedure Numbers, Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices. |
| Qualitative Coverage | Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews. |
| Data Sources | Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database. |
CONTACT US FOR ADDITIONAL INFORMATION
For full segmentation and any questions regarding research coverage, please contact us for a complimentary demo of the full report.
